Nivolumab with chemotherapy in pleural mesothelioma after surgery: The NICITA trial. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...
Data presented by Dr. Dean Fennell in an oral presentation at the IASLC 2023 World Conference on Lung Cancer in Singapore CAMBRIDGE, Mass.--(BUSINESS WIRE)--RS Oncology, a clinical stage biotechnology ...
SWOG 0722: A phase II study of mTOR inhibitor everolimus (RAD001) in malignant pleural mesothelioma (MPM). This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...
While many patients with mesothelioma — a type of rare cancer that most commonly occurs in the membrane between the lungs and the chest wall — may not be eligible to undergo surgery, drug advancements ...
Mesothelioma is an aggressive tumor with a poor prognosis. Histological diagnosis of mesothelioma using limited tissue samples can be challenging. Carbonic anhydrase IX (CAIX) is a transmembrane ...
(a) Hematoxylin and eosin (H&E) stain (100×) on a needle biopsy specimen showing clusters of epithelioid tumor cells in a fibrotic stroma. (b) Corresponding area to (a) with positive nuclear and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results